Acute stroke trials: Strengthening the underpowered

被引：10
作者：
Furlan, AJ [1 ]
机构：
[1] Cleveland Clin Fdn, Dept Neurol, Cleveland Clin, Cerebrovasc Ctr,Sect Stroke & Neurol Intens Care, Cleveland, OH 44195 USA
来源：
STROKE | 2002年 / 33卷 / 06期
关键词：
D O I：
10.1161/01.STR.0000018645.04200.7D
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1450 / 1451
页数：2
相关论文
共 7 条
  • [1] Could stroke trials be missing important treatment effects?
    Berge, E
    Barer, D
    [J]. CEREBROVASCULAR DISEASES, 2002, 13 (01) : 73 - 75
  • [2] Recommendations for standards regarding preclinical neuroprotective and restorative drug development
    Feinklestein, SP
    Fisher, M
    Furland, AJ
    Goldstein, LB
    Gorelick, PB
    Kaste, M
    Lees, KR
    Traystman, RJ
    Albers, GW
    Anwer, UE
    Ashwood, T
    Barone, FC
    Basta, SL
    Bogousslavsky, J
    Buchan, AM
    Cady, WJ
    Chan, PH
    Clemens, JA
    Cox, BF
    Craddock, RE
    Cramer, SC
    del Zoppo, GJ
    Dielrich, WD
    Elliott, P
    Faden, AI
    Feuerstein, GZ
    Ginsberg, MD
    Gold, M
    Greene, WL
    Hall, ED
    Hsu, CY
    Hunter, AJ
    Lai, M
    Lesko, LM
    Levy, DE
    Li, FH
    Locke, KW
    Lodge, D
    Lowe, D
    Marcoux, FW
    McCulloch, J
    McDermott, J
    Meibach, R
    Messersmith, EK
    Moseley, M
    Moskowitz, MA
    Mueller, AL
    Munro, F
    Nudo, RJ
    Oeda, J
    [J]. STROKE, 1999, 30 (12) : 2752 - 2758
  • [3] CVA: Reducing the risk of a confused vascular analysis - The Feinberg lecture
    Furlan, AJ
    [J]. STROKE, 2000, 31 (06) : 1451 - 1456
  • [4] Neuroprotection is unlikely to be effective in humans using current trial designs
    Grotta, J
    [J]. STROKE, 2002, 33 (01) : 306 - 307
  • [5] Neuroprotection is unlikely to be effective in humans using current trial designs: An opposing view
    Lees, KR
    [J]. STROKE, 2002, 33 (01) : 308 - 309
  • [6] Heterogeneity of stroke pathophysiology and neuroprotective clinical trial design
    Muir, KW
    [J]. STROKE, 2002, 33 (06) : 1545 - 1550
  • [7] Have randomized controlled trials of neuroprotective drugs been underpowered? An illustration of three statistical principles
    Samsa, GP
    Matchar, DB
    [J]. STROKE, 2001, 32 (03) : 669 - 674
1